BioCentury
ARTICLE | Company News

Almirall, Kyorin in COPD deal in Japan

February 25, 2011 12:54 AM UTC

Almirall S.A. (Madrid:ALM) granted Kyorin Pharmaceutical Co. Ltd. (Tokyo:4569) exclusive rights in Japan to develop and commercialize chronic obstructive pulmonary disease (COPD) candidate aclidinium bromide. Almirall will receive an upfront payment and milestones totaling up to EUR 38 million ($52.1 million). Almirall is also eligible for escalating royalties. ...